eISSN: 3023-6940
  • Home
  • First virtual uro-oncology meeting during the COVID-19 pandemic: 10th Online Eurasian Uro-oncology Congress

Original Research

First virtual uro-oncology meeting during the COVID-19 pandemic: 10th Online Eurasian Uro-oncology Congress


1 Istanbul Medeniyet University, Faculty of Medicine, Department of Urology, Istanbul, Turkey
2 Koç University, School of Medicine, Department of Urology, Istanbul, Turkey
3 University of Health Sciences, Adana City Training and Research Hospital, Department of Oncology, Adana, Turkey
4 Istanbul Medeniyet University, Faculty of Medicine, Department of Oncology, Istanbul, Turkey
5 Istanbul Medipol University, Faculty of Medicine, Department of Urology, Istanbul, Turkey


DOI : 10.33719/yud.2021;16-3-865211
New J Urol. 2021;16(3): 215-220

Abstract

Objective: We investigated the impact of transurethral resection of the prostate (TUR-P) on perioperative outcomes in patients who underwent robot assisted radical prostatectomy (RARP).

Material and Methods: A total of 752 cases per- formed by 3 surgeons between February 2009 and December 2017 were reviewed retrospectively. First 100 cases of each surgeon were not included to ex- clude the learning curve effect. All patients (n = 452) were divided into two groups according to having a previous TUR-P history as Group 1 = patients with TUR-P history (n = 38), Group 2 = patients without TUR-P history (n = 414).

Results: Mean patient age was 68.3± 5.9 ver- sus 63.3±6.8 years p=0.00; mean console time was 144.3±37.1 versus 124.6±24.0 minutes, p=0.02; blad- der neck reconstruction was 31.6% versus 16.7%, p=0.02; transurethral catheter removal time was 11.3±5.1 versus 8.6±2.7 days, p=0.00; for groups 1 and 2, respectively. Positive surgical margin rates were 26.3% versus 27.3%, p=0.897; erectile func- tion (IIEF≥17) rates on postoperative 12th-month were 60% versus 67%, p=0.644 for groups 1 and 2, respectively. First 3 months continence rates were 52.6% versus 72%, p=0.035 for groups 1 and group

2, respectively. Postoperative 12. month continence rates were similar for group 1 and 2(94.7% vs 97.3%; p=0.562).

Conclusion: RARP after TUR-P has similar oncological outcomes, longer operative time, worse postoperative early continence acquisition rates and longer urethral catheter removal time.

Keywords: Prostate cancer, robotic prostatec- tomy, TUR-P, previous surgery


Abstract

Objective: We investigated the impact of transurethral resection of the prostate (TUR-P) on perioperative outcomes in patients who underwent robot assisted radical prostatectomy (RARP).

Material and Methods: A total of 752 cases per- formed by 3 surgeons between February 2009 and December 2017 were reviewed retrospectively. First 100 cases of each surgeon were not included to ex- clude the learning curve effect. All patients (n = 452) were divided into two groups according to having a previous TUR-P history as Group 1 = patients with TUR-P history (n = 38), Group 2 = patients without TUR-P history (n = 414).

Results: Mean patient age was 68.3± 5.9 ver- sus 63.3±6.8 years p=0.00; mean console time was 144.3±37.1 versus 124.6±24.0 minutes, p=0.02; blad- der neck reconstruction was 31.6% versus 16.7%, p=0.02; transurethral catheter removal time was 11.3±5.1 versus 8.6±2.7 days, p=0.00; for groups 1 and 2, respectively. Positive surgical margin rates were 26.3% versus 27.3%, p=0.897; erectile func- tion (IIEF≥17) rates on postoperative 12th-month were 60% versus 67%, p=0.644 for groups 1 and 2, respectively. First 3 months continence rates were 52.6% versus 72%, p=0.035 for groups 1 and group

2, respectively. Postoperative 12. month continence rates were similar for group 1 and 2(94.7% vs 97.3%; p=0.562).

Conclusion: RARP after TUR-P has similar oncological outcomes, longer operative time, worse postoperative early continence acquisition rates and longer urethral catheter removal time.

Keywords: Prostate cancer, robotic prostatec- tomy, TUR-P, previous surgery